Mobile-health Network Solutions ['MaNaDr'](NASDAQ:MNDR), a leading Asia-Pacific telehealth provider, today announced updated pricing for its medical weight management program, improving the affordability and accessibility of GLP-1 (glucagon-like peptide-1) receptor agonist medications?in the Asia-Pacific (APAC) region.
Mobile-health Network Solutions Reported Wednesday It Will Offer GLP-1 Injectables for Medical Weight Loss From $10/Day
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.